Following the success of our first digital event in July with the likes of Carl June leading the keynote, the Onco Cell Therapy Summit is returning in its most interactive form ever with 20+ panel conversations, townhall meetings, roundtable sessions and coffee break style networking. The Global Onco Cell Therapy Summit is an online event, January 19th -...
The COVID-19 pandemic makes it necessary for leading experts from across disciplines and geographies to come together to jointly address the challenges we are facing when coping with the disruptive nature of the coronavirus SARS-CoV-2 pandemic is having on our healthcare system and our society as a whole. The tasks upon us are enormous and...
Prueba
DIA's Pharmacovigilance and Risk Management Strategies Conference provides the foundation for strong strategic planning and practical decision-making in your pharmacovigilance programs. Developed by recognized experts from the biopharmaceutical industry and global regulatory agencies, this conference provides the background, context, and opportunities to discuss current challenges and to problem-solve around issues that matter most to professionals working in...
You are invited to sign up and present at the next SV Global Investing Summit –Lifesciences Track on the 26th of January. You can visit pitchglobal.com for more details like the list of hundreds of investing firms which attends this Summit or visit the website of the Event Host, Dr Fred Cohen, Founding President of...
Develop a strong protocol, reduce expected costs, and increase patient participation through the revolution of siteless clinical trials Based on the success of our first Virtual Clinical Trials event and the Virtual Clinical Trials Online, we are pleased to announce the second annual event. This event features unmatched networking opportunities, presentations, panels, and roundtables all...
The inaugural Gene Therapy Medical Affairs Summit is dedicated to exploring the pivotal internal and external role that Medical Affairs plays in delivering gene therapies to patients. Industry pioneers from leading pharma and biotech companies at various stages of development and commercialization including Novartis Gene Therapy, Orchard Therapeutics & Bluebird Bio will share how to engage effectively with internal clinical and commercial teams as well as external HCPs,...
RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy personalised medicines, and treatment of genetic, infectious and chronic diseases. This is reflected with the value of the global antisense & RNA therapeutics market expected to reach USD 1.81 billion by 2025, growing at a CAGR of 7.5%. Furthermore, the recent advent...
3D Cell Culture has gained increasing momentum in the pharmaceutical industry over recent years, with the global 3D Cell Culture market predicted to reach a value of $3.2 Billion by 2027, researchers globally are realising the growing potential of in vitro applications for drug discovery, predictivity and validation, safety and toxicity. Rising demand for tissue...
Brandeis University was founded in 1948 by the American Jewish community at a time when Jews and other ethnic and racial minorities, and women, faced discrimination in higher education. Brandeis’ visionary founders established a nonsectarian research university that welcomed talented faculty and students of all backgrounds and beliefs. From the outset, Brandeis focused on undergraduate...
Building upon nearly 70 years of research in sickle cell disease (SCD) pathology, voxelotor, an HbS polymerization inhibitor, was developed to treat the root cause of SCD pathophysiology. In 2019, the FDA granted Oxbryta® (Voxelotor) accelerated approval using hemoglobin, a biologic surrogate endpoint, indicative of reduced SCD hemolysis. In this presentation, we will share the...
oin Biocom, Jones Day, and Deloitte for the next installment of the TECH+BIOTECH+MEDTECH (T+B+M) Virtual Series. Please join us to hear remarks from Dr. Ira Kalish followed by a fireside chat with Joe Panetta, CEO Biocom, assessing the economic outlook and trends for 2021 as the U.S. and the world seek to emerge from COVID...
